Baclofen vs placebo
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether baclofen changes AW symptoms (CIWA‐Ar score) compared with chlordiazepoxide (very low certainty).
It is very uncertain whether baclofen changes global improvement compared with chlordiazepoxide (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether baclofen changes AEs compared with chlordiazepoxide (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether baclofen changes dropouts compared with chlordiazepoxide (very low certainty).
It is very uncertain whether baclofen changes dropouts due to AEs compared with chlordiazepoxide (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Δ9‐Tetrahydrocannabinol preparation showed no clear difference in participants abstinent at end of treatment compared with placebo (moderate certainty).
Mixed action antidepressant showed no clear difference in participants experiencing adverse effects compared with placebo (low certainty).
Mixed action antidepressant showed no clear difference in participants withdrawn due to adverse effects compared with placebo (low certainty).
Mixed action antidepressant showed no clear difference in completion of scheduled treatment compared with placebo (low certainty).